Advance in adoptive immunotherapy on melanoma
10.3760/cma.j.cn114453-20210312-00112
- VernacularTitle:过继性免疫疗法在黑色素瘤中的研究进展
- Author:
Zixu GAO
1
;
Chuanyuan WEI
;
Yuhong ZHOU
;
Jianying GU
Author Information
1. 复旦大学附属中山医院整形外科，上海 200032
- Keywords:
Melanoma;
Adoptive immunotherapy;
Tumor-infiltrating lymphocyte
- From:
Chinese Journal of Plastic Surgery
2023;39(1):95-100
- CountryChina
- Language:Chinese
-
Abstract:
Melanoma is the most malignant skin tumor, which is characterized by early metastasis and poor prognosis. In recent years, adoptive immunotherapy, as a new immunotherapy, has made great breakthrough in treatment of solid tumors. Represented by tumor-infiltrating lymphocyte, adoptive immunotherapy exhibits remarkable effects in melanoma. Its combination with immunotherapy or targeted therapy will be a certain trend for future development, while the large-scale clinical study on adoptive immunotherapy remains to be carried out. This article reviews the research progress of adoptive immunotherapy on melanoma.
